logo
#

Latest news with #ResearchReport

Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN) was downgraded to a Sell Rating at Macquarie
Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN) was downgraded to a Sell Rating at Macquarie

Business Insider

time29-06-2025

  • Business
  • Business Insider

Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN) was downgraded to a Sell Rating at Macquarie

Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh (CRN – Research Report) received a Sell rating and a A$0.11 price target from Macquarie analyst Robert Stein on June 27. The company's shares closed last Friday at A$0.14. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Stein covers the Basic Materials sector, focusing on stocks such as Mineral Resources Limited, Champion Iron, and Iluka Resources Limited. According to TipRanks, Stein has an average return of -2.0% and a 45.39% success rate on recommended stocks. Currently, the analyst consensus on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh is a Hold with an average price target of A$0.19. Based on Coronado Global Resources Inc. Shs Chess Depository Interests Repr 10 Sh's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$526.42 million and a GAAP net loss of A$54.08 million. In comparison, last year the company earned a revenue of A$997.01 million and had a GAAP net loss of A$32.31 million

Raymond James Keeps Their Buy Rating on TECSYS Inc. J (TCS)
Raymond James Keeps Their Buy Rating on TECSYS Inc. J (TCS)

Business Insider

time28-06-2025

  • Business
  • Business Insider

Raymond James Keeps Their Buy Rating on TECSYS Inc. J (TCS)

Raymond James analyst Steven Li maintained a Buy rating on TECSYS Inc. J (TCS – Research Report) yesterday and set a price target of C$50.00. The company's shares closed yesterday at C$36.40. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Li covers the Technology sector, focusing on stocks such as Kraken Robotics Systems Inc, CGI, and BlackBerry. According to TipRanks, Li has an average return of 2.0% and a 44.25% success rate on recommended stocks. Currently, the analyst consensus on TECSYS Inc. J is a Moderate Buy with an average price target of C$48.00, representing a 31.87% upside. In a report released yesterday, Stifel Nicolaus also maintained a Buy rating on the stock with a C$48.00 price target. TCS market cap is currently C$540M and has a P/E ratio of 120.61. Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TCS in relation to earlier this year.

Clear Street downgrades Crispr Therapeutics AG (CRSP) to a Hold
Clear Street downgrades Crispr Therapeutics AG (CRSP) to a Hold

Business Insider

time27-06-2025

  • Business
  • Business Insider

Clear Street downgrades Crispr Therapeutics AG (CRSP) to a Hold

Crispr Therapeutics AG (CRSP – Research Report) received a Hold rating and price target from Clear Street analyst William Maughan today. The company's shares closed today at $46.70. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Maughan covers the Healthcare sector, focusing on stocks such as Crispr Therapeutics AG, Y-Mabs Therapeutics, and Delcath Systems. According to TipRanks, Maughan has an average return of 19.2% and a 48.15% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Crispr Therapeutics AG with a $68.65 average price target, which is a 47.00% upside from current levels. In a report released today, Barclays also reiterated a Hold rating on the stock with a $42.00 price target.

EVgo (EVGO) Gets a Buy from Evercore ISI
EVgo (EVGO) Gets a Buy from Evercore ISI

Business Insider

time18-06-2025

  • Business
  • Business Insider

EVgo (EVGO) Gets a Buy from Evercore ISI

Evercore ISI analyst James West maintained a Buy rating on EVgo (EVGO – Research Report) yesterday and set a price target of $4.00. The company's shares closed yesterday at $4.52. Confident Investing Starts Here: According to TipRanks, West is ranked #9438 out of 9595 analysts. The word on The Street in general, suggests a Strong Buy analyst consensus rating for EVgo with a $5.86 average price target, a 29.65% upside from current levels. In a report released yesterday, UBS also reiterated a Buy rating on the stock with a $5.00 price target. Based on EVgo's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $75.29 million and a GAAP net loss of $26.05 million. In comparison, last year the company earned a revenue of $55.16 million and had a GAAP net loss of $9.77 million Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EVGO in relation to earlier this year. Last month, DENNIS G KISH, the President of EVGO sold 120,000.00 shares for a total of $444,874.95.

Berenberg Bank Reaffirms Their Hold Rating on Ibstock (IBST)
Berenberg Bank Reaffirms Their Hold Rating on Ibstock (IBST)

Business Insider

time18-06-2025

  • Business
  • Business Insider

Berenberg Bank Reaffirms Their Hold Rating on Ibstock (IBST)

Berenberg Bank analyst reiterated a Hold rating on Ibstock (IBST – Research Report) yesterday and set a price target of p200.00. The company's shares closed today at p157.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ibstock with a p213.20 average price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store